$5.06
1.98%
Downside
Day's Volatility :5.34%
Upside
3.44%
31.03%
Downside
52 Weeks Volatility :54.08%
Upside
33.42%
Period | Meiragtx Holdings Plc | Sector (Health Care) | Index (Russel 2000) |
---|---|---|---|
3 Months | 6.04% | 6.5% | 0.0% |
6 Months | -24.59% | 7.1% | 0.0% |
1 Year | -21.21% | 9.8% | 0.0% |
3 Years | -64.38% | 14.2% | -20.2% |
Market Capitalization | 293.2M |
Book Value | $1.89 |
Earnings Per Share (EPS) | -1.19 |
Wall Street Target Price | 21.2 |
Profit Margin | 0.0% |
Operating Margin TTM | -6710.47% |
Return On Assets TTM | -31.82% |
Return On Equity TTM | -69.93% |
Revenue TTM | 11.4M |
Revenue Per Share TTM | 0.19 |
Quarterly Revenue Growth YOY | -79.10000000000001% |
Gross Profit TTM | 15.9M |
EBITDA | -138.2M |
Diluted Eps TTM | -1.19 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -1.64 |
EPS Estimate Next Year | 1.64 |
EPS Estimate Current Quarter | -0.5 |
EPS Estimate Next Quarter | -0.49 |
What analysts predicted
Upside of 318.97%
Sell
Neutral
Buy
Meiragtx Holdings Plc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
![]() Meiragtx Holdings Plc | 20.9% | -24.59% | -21.21% | -64.38% | -81.81% |
![]() Moderna, Inc. | -1.67% | 18.26% | -0.21% | -64.15% | 752.69% |
![]() Regeneron Pharmaceuticals, Inc. | -0.46% | 13.21% | 45.59% | 84.19% | 244.2% |
![]() Novo Nordisk A/s | -11.0% | 18.31% | 61.56% | 186.46% | 423.59% |
![]() Vertex Pharmaceuticals Incorporated | 3.85% | 14.43% | 39.88% | 147.45% | 195.07% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
![]() Meiragtx Holdings Plc | NA | NA | NA | -1.64 | -0.7 | -0.32 | NA | 1.89 |
![]() Moderna, Inc. | 24.73 | NA | 0.0 | -7.19 | -0.38 | -0.16 | NA | 33.47 |
![]() Regeneron Pharmaceuticals, Inc. | 31.35 | 31.35 | 1.46 | 44.44 | 0.15 | 0.08 | NA | 250.15 |
![]() Novo Nordisk A/s | 44.28 | 44.28 | 2.36 | 3.43 | 1.0 | 0.25 | 0.01 | 22.18 |
![]() Vertex Pharmaceuticals Incorporated | 31.85 | 31.85 | 0.53 | 16.98 | 0.24 | 0.13 | NA | 71.8 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
![]() Meiragtx Holdings Plc | Buy | $293.2M | -81.81% | NA | 0.0% |
![]() Moderna, Inc. | Buy | $45.3B | 752.69% | 24.73 | -115.82% |
![]() Regeneron Pharmaceuticals, Inc. | Buy | $116.9B | 244.2% | 31.35 | 29.45% |
![]() Novo Nordisk A/s | Buy | $572.0B | 423.59% | 44.28 | 36.55% |
![]() Vertex Pharmaceuticals Incorporated | Buy | $126.7B | 195.07% | 31.85 | 39.46% |
Insights on Meiragtx Holdings Plc
Revenue is down for the last 3 quarters, 5.10M → 697.0K (in $), with an average decrease of 62.9% per quarter
Netprofit is down for the last 2 quarters, 20.21M → -20.44M (in $), with an average decrease of 201.1% per quarter
In the last 1 year, Novo Nordisk A/s has given 61.6% return, outperforming this stock by 82.8%
In the last 3 years, Novo Nordisk A/s has given 186.5% return, outperforming this stock by 250.9%
Perceptive Advisors LLC
Johnson & Johnson
Adage Capital Partners Gp LLC
Prosight Management, LP
683 Capital Management LLC
BlackRock Inc
meiragtx, a london and new york-based gene therapy company, is committed to the development of novel gene therapies to transform the lives of patients suffering from acquired and inherited disorders. we are pioneering the use of gene therapy to treat devastating neurodegenerative diseases such as alzheimer’s disease (ad), parkinson’s disease (pd), and amyotrophic lateral sclerosis (als). we are developing innovative gene therapies for ocular diseases including rare inherited blindness and age-related macular degeneration (amd). meiragtx is also establishing treatments for xerostomia, a frequent and debilitating side effect of radiation treatment used in head and neck cancers. our revolutionary gene regulation technologies promise to transform the way gene therapy can be applied and create new paradigms for biologic therapeutics.
Organization | Meiragtx Holdings Plc |
Employees | 402 |
CEO | Dr. Alexandria Forbes Ph.D. |
Industry | Health Technology |
A Spac I Acquisition Corp
$5.06
-0.59%
Keyarch Acquisition Corp
$5.06
-0.59%
Connexa Sports Technologies Inc
$5.06
-0.59%
Us Value Etf
$5.06
-0.59%
First Wave Biopharma Inc
$5.06
-0.59%
Global X Msci Next Emerging
$5.06
-0.59%
Fat Projects Acquisition Corp
$5.06
-0.59%
Capital Link Global Fintech
$5.06
-0.59%
Applied Uv Inc
$5.06
-0.59%